AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33132077 — intervention group
Group type: EXPERIMENTAL
Intervention: OCTAID (online tool for diagnosis of macular lesions)
Number of subjects: 118
Study 33132077 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (standard OCT educational material)
Number of subjects: 118
Study 32859183 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise combined with whole body vibration (vertical, 40 Hz, amplitude 2-4 mm)
Number of subjects: 50
Study 32859183 — intervention group
Group type: COMPARATOR
Intervention: Control group (exercise without vibration)
Number of subjects: 50
Study 35689370 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused Extracorporeal Shock Wave Therapy (fESWT) at the lumbar and sacral spine (0.15 mJ/mm², 1000 pulses, 4 Hz)
Number of subjects: 40
Study 35689370 — intervention group
Group type: COMPARATOR
Intervention: Sham fESWT
Number of subjects: 40
Study 35689370 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (fESWT and sham) with stabilization training (45 minutes, once a day, 5 days a week)
Number of subjects: 40
Study 34534863 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection extended-release naltrexone (XR-NTX), delivered approximately every 28 days
Number of subjects: 570
Study 34534863 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily sublingual buprenorphine-naloxone (BUP-NX)
Number of subjects: 570
Study 34534863 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimated individualized treatment rule for OUD
Number of subjects: 570
Study 34534863 — intervention group
Group type: EXPERIMENTAL
Intervention: Simpler alternative estimated rule (homeless participants treated with XR-NTX, stably housed participants treated with BUP-NX)
Number of subjects: 570
Study 36357824 — intervention group
Group type: EXPERIMENTAL
Intervention: Conversation aid intervention
Number of subjects: 0
Study 36357824 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32946039 — intervention group
Group type: EXPERIMENTAL
Intervention: Bloodletting puncture at hand twelve Jing-Well points (HTWPs)
Number of subjects: 360
Study 32946039 — intervention group
Group type: COMPARATOR
Intervention: Routine Western medicine
Number of subjects: 360
Study 32487150 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium oxide (500 mg thrice daily)
Number of subjects: 0
Study 32487150 — intervention group
Group type: COMPARATOR
Intervention: Naldemedine (0.2 mg once daily)
Number of subjects: 0
Study 35488084 — intervention group
Group type: EXPERIMENTAL
Intervention: lenrispodun 1.0 mg
Number of subjects: 26
Study 35488084 — intervention group
Group type: EXPERIMENTAL
Intervention: lenrispodun 10.0 mg
Number of subjects: 26
Study 35488084 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 26
Study 35488084 — intervention group
Group type: EXPERIMENTAL
Intervention: lenrispodun
Number of subjects: 26
Study 34162218 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg/d
Number of subjects: 1120
Study 34162218 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1120
Study 34162218 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 1120
Study 34162218 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin and Placebo
Number of subjects: 1120
Study 32784346 — intervention group
Group type: EXPERIMENTAL
Intervention: IV vortioxetine 25 mg plus daily oral vortioxetine 10 mg
Number of subjects: 80
Study 32784346 — intervention group
Group type: COMPARATOR
Intervention: IV placebo plus daily oral placebo
Number of subjects: 80
Study 36379827 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Vocal Function Exercises with reduced requirement for maximally sustained phonation (midpoint group MG)
Number of subjects: 34
Study 36379827 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocal Function Exercises (traditional group TG)
Number of subjects: 34
Study 36379827 — intervention group
Group type: COMPARATOR
Intervention: Modified Vocal Function Exercises with removed requirement for maximally sustained phonation (baseline group BG)
Number of subjects: 34
Study 35225388 — intervention group
Group type: EXPERIMENTAL
Intervention: Home solar lighting system at no cost to study participants
Number of subjects: 80
Study 33185372 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous cervical nucleoplasty (PCN)
Number of subjects: 48
Study 33185372 — intervention group
Group type: COMPARATOR
Intervention: Anterior cervical discectomy (ACD)
Number of subjects: 48
Study 33185372 — intervention group
Group type: COMPARATOR
Intervention: ACD
Number of subjects: 48
Study 33185372 — intervention group
Group type: EXPERIMENTAL
Intervention: PCN
Number of subjects: 48
Study 35393874 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes app
Number of subjects: 154
Study 35393874 — intervention group
Group type: COMPARATOR
Intervention: Standard diabetes care
Number of subjects: 154
Study 33648515 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (EMPA) 10 mg/day in humans
Number of subjects: 80
Study 33648515 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (EMPA) 30 mg/kg in mice
Number of subjects: 80
Study 33648515 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (EMPA)
Number of subjects: 80
Study 33648515 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32894959 — intervention group
Group type: EXPERIMENTAL
Intervention: Pectoral nerve block with 30 ml ropivacaine 0.375% (Pecs group)
Number of subjects: 60
Study 32894959 — intervention group
Group type: COMPARATOR
Intervention: Thoracic paravertebral block with 20 ml ropivacaine 0.5% (TPVB group)
Number of subjects: 60
Study 32894959 — intervention group
Group type: EXPERIMENTAL
Intervention: Pecs group
Number of subjects: 60
Study 32894959 — intervention group
Group type: COMPARATOR
Intervention: TPVB group
Number of subjects: 60
Study 36006505 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy (CRT)
Number of subjects: 71
Study 36006505 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (CT)
Number of subjects: 71
Study 34962560 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based self-management program (n=116)
Number of subjects: 230
Study 34962560 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=113)
Number of subjects: 230
Study 36244254 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality (IVR) training
Number of subjects: 107
Study 36244254 — intervention group
Group type: COMPARATOR
Intervention: Control group (15-min 2D video)
Number of subjects: 107
Study 33902979 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional method (verbal explanation supported with the BOS leaflet)
Number of subjects: 64
Study 33902979 — intervention group
Group type: COMPARATOR
Intervention: 3D animated content based on the BOS leaflet
Number of subjects: 64
Study 33735884 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m2 and carboplatin AUC 5 every 3 weeks
Number of subjects: 164
Study 33735884 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel 80 mg/m2 on day 1, day 8, and day 15 with carboplatin AUC 5 every 4 weeks for 4 cycles
Number of subjects: 164
Study 33735884 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed-carboplatin
Number of subjects: 164
Study 33735884 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-carboplatin
Number of subjects: 164
Study 33406480 — intervention group
Group type: EXPERIMENTAL
Intervention: Session Ratings of Perceived Exertion (sRPE) using the CR100 scale
Number of subjects: 59
Study 32603389 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser ablative fractional resurfacing (AFR) followed by ALA photodynamic therapy (PDT)
Number of subjects: 19
Study 32603389 — intervention group
Group type: COMPARATOR
Intervention: ALA photodynamic therapy (PDT) alone
Number of subjects: 19
Study 34718434 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab weekly (TCZ QW)
Number of subjects: 250
Study 34718434 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab every-other-week (TCZ Q2W)
Number of subjects: 250
Study 34718434 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 33736638 — intervention group
Group type: EXPERIMENTAL
Intervention: NCB-PT® (9 patients)
Number of subjects: 28
Study 33736638 — intervention group
Group type: COMPARATOR
Intervention: VA-LCP® (19 patients)
Number of subjects: 28
Study 32393496 — intervention group
Group type: EXPERIMENTAL
Intervention: 3,600 mg MHAA4549A + OTV
Number of subjects: 166
Study 32393496 — intervention group
Group type: EXPERIMENTAL
Intervention: 8,400 mg MHAA4549A + OTV
Number of subjects: 166
Study 32393496 — intervention group
Group type: COMPARATOR
Intervention: Placebo + OTV
Number of subjects: 166
Study 32393496 — intervention group
Group type: EXPERIMENTAL
Intervention: MHAA4549A + OTV
Number of subjects: 166
Study 32393496 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 166
Study 34534556 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichoptic digital therapeutic used at home for 1 hour per day, 6 days per week, with full-time glasses wear.
Number of subjects: 105
Study 34534556 — intervention group
Group type: COMPARATOR
Intervention: Control group continued wearing glasses full-time alone.
Number of subjects: 105
Study 34155736 — intervention group
Group type: EXPERIMENTAL
Intervention: Unicornuate uterus (UU)
Number of subjects: 44
Study 34155736 — intervention group
Group type: COMPARATOR
Intervention: Normal uterus (control)
Number of subjects: 44
Study 33026749 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% foam plus apremilast
Number of subjects: 28
Study 33026749 — intervention group
Group type: COMPARATOR
Intervention: Vehicle foam plus apremilast
Number of subjects: 28
Study 35688490 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronised progesterone (Utrogestan® 200mg) + transdermal oestradiol (Evorel® Patches 50mcg/day)
Number of subjects: 57
Study 35688490 — intervention group
Group type: COMPARATOR
Intervention: Medroxyprogesterone acetate (Provera® 10mg) + transdermal oestradiol (Evorel® Patches 50mcg/day)
Number of subjects: 57
Study 33472681 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma (single infusion) plus standard of care (SOC)
Number of subjects: 278
Study 33472681 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) alone
Number of subjects: 278
Study 32125903 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride extended-release capsules (MPH-MLR) 10 mg once daily, with weekly adjustments up to 40 mg.
Number of subjects: 119
Study 32125903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 32125903 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride extended-release capsules (MPH-MLR)
Number of subjects: 119
Study 35266244 — intervention group
Group type: EXPERIMENTAL
Intervention: 10+ hours of sleep (sleep extension)
Number of subjects: 12
Study 35266244 — intervention group
Group type: COMPARATOR
Intervention: 8 hours of sleep (control)
Number of subjects: 12
Study 35266244 — intervention group
Group type: EXPERIMENTAL
Intervention: Brisk walking (exercise)
Number of subjects: 12
Study 32031090 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser application prior to restoration with Universal Single Bond (Self Etch) and Grandio.
Number of subjects: 80
Study 32031090 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser application prior to restoration with Universal Single Bond (Total Etch) and Grandio.
Number of subjects: 80
Study 32031090 — intervention group
Group type: COMPARATOR
Intervention: Control group with Universal Single Bond (Self Etch) and Grandio without diode laser application.
Number of subjects: 80
Study 32031090 — intervention group
Group type: COMPARATOR
Intervention: Control group with Universal Single Bond (Total Etch) and Grandio without diode laser application.
Number of subjects: 80
Study 33268562 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibudilast
Number of subjects: 255
Study 33268562 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study 32507386 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-infusion donor-derived anti-CD19 CAR T cells
Number of subjects: 11
Study 34321181 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyhexamethylene biguanide discs
Number of subjects: 80
Study 34321181 — intervention group
Group type: COMPARATOR
Intervention: Standard unmedicated dressings
Number of subjects: 80
Study 34145052 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 148
Study 34145052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 35287091 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 5 mg/midazolam 5 mg IM
Number of subjects: 86
Study 35287091 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol 5 mg/lorazepam 2 mg IM
Number of subjects: 86
Study 34270425 — intervention group
Group type: EXPERIMENTAL
Intervention: Global Texture Randomization (GTR)
Number of subjects: 5
Study 34270425 — intervention group
Group type: EXPERIMENTAL
Intervention: Local Texture Randomization (LTR)
Number of subjects: 5
Study 34270425 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistency between GTR and LTR (CGL)
Number of subjects: 5
Study 35939501 — intervention group
Group type: EXPERIMENTAL
Intervention: UV-4 hydrochloride (UV-4B) at doses of 3, 10, 30, 90, 180, 360, 720, or 1000 mg
Number of subjects: 64
Study 35939501 — intervention group
Group type: EXPERIMENTAL
Intervention: UV-4 hydrochloride (UV-4B)
Number of subjects: 64
Study 35939501 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 33148955 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-g intravenous (IV) TXA prior to incision (single-dose IV group)
Number of subjects: 175
Study 33148955 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-g IV TXA prior to incision followed by 1-g IV TXA after arthrotomy wound closure (double-dose IV group)
Number of subjects: 175
Study 33148955 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-g IV TXA prior to incision and 1-g intraoperative topical TXA (combined IV and topical group)
Number of subjects: 175
Study 33148955 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 doses totaling 1,950-mg oral TXA (multidose oral group)
Number of subjects: 175
Study 36115179 — intervention group
Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 144
Study 36115179 — intervention group
Group type: COMPARATOR
Intervention: Navigation assistance
Number of subjects: 144
Study 36115179 — intervention group
Group type: COMPARATOR
Intervention: Patient-specific instrumentation (PSI)
Number of subjects: 144
Study 33715251 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution
Number of subjects: 333
Study 33715251 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 333
Study 32762769 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological resilience (measured by the Asian Resilience Scale)
Number of subjects: 1743
Study 32762769 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive coping style (measured by the Simplified Coping Style Questionnaire)
Number of subjects: 1743
Study 32762769 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological resilience factors (mood control, self-plasticity, coping flexibility)
Number of subjects: 1743
Study 32762769 — intervention group
Group type: COMPARATOR
Intervention: Gender and major (Medical vs Non-medical students)
Number of subjects: 1743
Study 34038318 — intervention group
Group type: EXPERIMENTAL
Intervention: EHRs with P100 filters
Number of subjects: 16
Study 34038318 — intervention group
Group type: EXPERIMENTAL
Intervention: EHRs with N95 filters
Number of subjects: 16
Study 34038318 — intervention group
Group type: EXPERIMENTAL
Intervention: PAPRs
Number of subjects: 16
Study 34038318 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-facepiece respirators
Number of subjects: 16
Study 33198809 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics nomogram based on texture parameters and clinicopathological factors
Number of subjects: 544
Study 33198809 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics nomogram
Number of subjects: 544
Study 33726868 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual multicentre training initiative and remote source data verification audit
Number of subjects: 572
Study 35120150 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula supplementation (up to 59 milliliters administered daily for 30 days)
Number of subjects: 324
Study 35120150 — intervention group
Group type: COMPARATOR
Intervention: Breastfeeding alone (exclusive breastfeeding without supplementation)
Number of subjects: 324
Study 33610052 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer education model
Number of subjects: 88
Study 35669367 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise combined with diet intervention
Number of subjects: 104
Study 35669367 — intervention group
Group type: COMPARATOR
Intervention: Exercise and routine nursing (Control)
Number of subjects: 104
Study 33685740 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD/CAM cutting and drilling guides accompanied with pre‐bent titanium plates (group A)
Number of subjects: 50
Study 33685740 — intervention group
Group type: COMPARATOR
Intervention: CAD/CAM splints (group B)
Number of subjects: 50
Study 32401941 — intervention group
Group type: EXPERIMENTAL
Intervention: Music at 432 Hz (n=15)
Number of subjects: 42
Study 32401941 — intervention group
Group type: EXPERIMENTAL
Intervention: Music at 440 Hz (n=15)
Number of subjects: 42
Study 32401941 — intervention group
Group type: COMPARATOR
Intervention: No music (Control group, n=12)
Number of subjects: 42
Study 35819163 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine combined with dexamethasone (Group D)
Number of subjects: 60
Study 35819163 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine only (Group C)
Number of subjects: 60
Study 34274932 — intervention group
Group type: EXPERIMENTAL
Intervention: CatInfo tool (interactive computer-based tool with detailed audio-visual presentation)
Number of subjects: 61
Study 34274932 — intervention group
Group type: COMPARATOR
Intervention: Placebo video (control group)
Number of subjects: 61
Study 34274932 — intervention group
Group type: EXPERIMENTAL
Intervention: CatInfo tool satisfaction
Number of subjects: 61
Study 34274932 — intervention group
Group type: EXPERIMENTAL
Intervention: CatInfo tool usefulness
Number of subjects: 61
Study 36222185 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 6
Study 33768599 — intervention group
Group type: EXPERIMENTAL
Intervention: GDMT Team intervention
Number of subjects: 118
Study 33768599 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 118
Study 32783421 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injection
Number of subjects: 30
Study 35564709 — intervention group
Group type: EXPERIMENTAL
Intervention: Blueberry juice (60 mL per day for 20 days)
Number of subjects: 45
Study 35564709 — intervention group
Group type: COMPARATOR
Intervention: Placebo (60 mL per day for 20 days)
Number of subjects: 45
Study 34528089 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprafascial vancomycin powder
Number of subjects: 34
Study 34528089 — intervention group
Group type: COMPARATOR
Intervention: Control (no vancomycin powder)
Number of subjects: 34
Study 34615742 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror Cross Exercise (MCE)
Number of subjects: 39
Study 34615742 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinetic Chain Approach (KCA)
Number of subjects: 39
Study 34615742 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular training program)
Number of subjects: 39
Study 33803802 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g of oat oil with a high concentration (40%) of polar lipids (PLH)
Number of subjects: 20
Study 33803802 — intervention group
Group type: COMPARATOR
Intervention: 30 g of rapeseed oil (RSO)
Number of subjects: 20
Study 33803802 — intervention group
Group type: COMPARATOR
Intervention: 30 g of oat oil with a low concentration (4%) of polar lipids (PLL)
Number of subjects: 20
Study 33803802 — intervention group
Group type: COMPARATOR
Intervention: No added lipids (NL)
Number of subjects: 20
Study 33099836 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional Carbon Dioxide Laser (FCO2)
Number of subjects: 27
Study 33099836 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional Radiofrequency (FRF)
Number of subjects: 27
Study 33099836 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of FCO2 and FRF
Number of subjects: 27
Study 33099836 — intervention group
Group type: COMPARATOR
Intervention: Control (FRF side)
Number of subjects: 27
Study 34486480 — intervention group
Group type: EXPERIMENTAL
Intervention: Glaucoma
Number of subjects: 30097
Study 34486480 — intervention group
Group type: COMPARATOR
Intervention: Visual impairment (VI), AMD, and cataract
Number of subjects: 30097
Study 33292886 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy eating intervention consisting of sessions on breastfeeding (BF) and healthy complementary feeding promotion.
Number of subjects: 323
Study 33292886 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 323
Study 35616994 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 458
Study 35616994 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone intervention
Number of subjects: 458
Study 35616994 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 458
Study 32882447 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly aflibercept injections (2 mg)
Number of subjects: 40
Study 32882447 — intervention group
Group type: EXPERIMENTAL
Intervention: Quarterly aflibercept injections (2 mg)
Number of subjects: 40
Study 32882447 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (monthly and quarterly aflibercept injections)
Number of subjects: 40
Study 32590809 — intervention group
Group type: EXPERIMENTAL
Intervention: quetiapine plus sulforaphane (SFN)
Number of subjects: 100
Study 32590809 — intervention group
Group type: COMPARATOR
Intervention: quetiapine plus placebo
Number of subjects: 100
Study 36107843 — intervention group
Group type: EXPERIMENTAL
Intervention: OC‐01 0.03 mg BID
Number of subjects: 182
Study 36107843 — intervention group
Group type: EXPERIMENTAL
Intervention: OC‐01 0.06 mg BID
Number of subjects: 182